Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Jul;30(4):352-9.
doi: 10.1007/BF03007857.

Myocardial and systemic effects of nitroglycerin, given awake and during anaesthesia in coronary patients

Myocardial and systemic effects of nitroglycerin, given awake and during anaesthesia in coronary patients

E A Moffitt et al. Can Anaesth Soc J. 1983 Jul.

Abstract

The haemodynamic and myocardial energy-metabolic effects of intravenous nitroglycerin (NTG) were investigated in seven male patients about to undergo coronary artery bypass grafting. Effects of one mg of NTG given at a rate of 100 micrograms . min-1 to sedated, awake hypertensive patients, were compared to effects of the same dose of NTG in the same patients, after sternotomy. Coronary sinus flow was measured by a thermodilution catheter and myocardial oxygen consumption (MVO2) was calculated using the arterio-coronary sinus difference of oxygen content. With the patients awake, cardiac index and stroke volume and work indices fell during NTG administration. There was only a small fall in arterial pressure as heart rate and systemic resistance increased. Pulmonary capillary wedge pressure decreased but not MVO2. With NTG administration during anaesthesia, arterial pressure fell significantly to normal, as systemic resistance decreased, without a change in heart rate or cardiac index. Calculated MVO2 decreased as the arterial-coronary venous difference of oxygen content increased. Both oxygen and lactate balance of the myocardium were maintained. NTG given during anaesthesia was more effective in reducing blood pressure and MVO2 than when given to awake patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Anesth Analg. 1982 Feb;61(2):109-14 - PubMed
    1. Anesth Analg. 1982 Dec;61(12):979-85 - PubMed
    1. Clin Chem. 1967 Apr;13(4):314-25 - PubMed
    1. Anaesthesist. 1978 May;27(5):223-7 - PubMed
    1. Circulation. 1978 Apr;57(4):778-86 - PubMed

MeSH terms

LinkOut - more resources